U.S. Peripheral Vascular Devices Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview
The U.S. Peripheral Vascular Devices Market is anticipated to grow from USD 2,945.00 million in 2023 to USD 4,947.26 million by 2032, registering a compound annual growth rate (CAGR) of 6.70%.
Growth in this market is primarily driven by the increasing incidence of peripheral artery diseases (PAD) and the expanding geriatric demographic—both significant contributors to vascular health complications. Technological progress, including the adoption of minimally invasive procedures and the evolution of device engineering, is enhancing treatment outcomes and safety, fueling market demand. A heightened emphasis on early diagnosis and preventive care is accelerating the uptake of peripheral vascular devices. The emergence of bioresorbable technologies and a shift toward outpatient vascular interventions are reshaping care delivery models. Innovations in materials and the advancement of next-generation stents and catheters are further improving therapeutic efficacy. Additionally, favorable reimbursement frameworks and increased healthcare investment are creating a supportive environment for broader device utilization. Collectively, these factors are expected to sustain market growth over the forecast period.
Market Drivers
Aging Demographics and Healthcare Spending Growth
A key market driver is the aging U.S. population, which is increasingly prone to vascular disorders such as PAD. By 2034, the population aged 65 and older is projected to exceed 77 million, significantly boosting demand for vascular interventions. This demographic shift, coupled with rising healthcare expenditures and enhanced access to medical services, is fostering greater adoption of peripheral vascular devices. These trends are expanding treatment accessibility, thereby accelerating market growth.
Market Challenges Analysis
High Cost of Advanced Peripheral Vascular Devices
The high cost associated with peripheral vascular devices remains a significant challenge for market expansion. Cutting-edge interventions, including stents, balloons, and catheters, entail extensive R&D and regulatory processes, resulting in elevated production costs. For example, the development of new stent technologies requires comprehensive clinical validation and approval, which contributes to pricing pressures. These expenses are frequently transferred to healthcare providers and patients, limiting affordability—particularly for those with limited or no insurance coverage. Although increased demand may offset some financial burdens, the introduction of premium technologies such as bioresorbable stents and drug-eluting devices intensifies the cost barrier, constraining widespread adoption.
Market Segmentation
By Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Guidewires
Others
By End-User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Geography:
Western United States
Midwestern United States
Southern United States
Northeastern United States
Key Player Analysis
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
Terumo Corporation
Becton, Dickinson and Company
Cardinal Health
Cook Medical
Koninklijke Philips N.V.
AngioDynamics, Inc.
Biotronik SE & Co. KG
The U.S. Peripheral Vascular Devices Market is anticipated to grow from USD 2,945.00 million in 2023 to USD 4,947.26 million by 2032, registering a compound annual growth rate (CAGR) of 6.70%.
Growth in this market is primarily driven by the increasing incidence of peripheral artery diseases (PAD) and the expanding geriatric demographic—both significant contributors to vascular health complications. Technological progress, including the adoption of minimally invasive procedures and the evolution of device engineering, is enhancing treatment outcomes and safety, fueling market demand. A heightened emphasis on early diagnosis and preventive care is accelerating the uptake of peripheral vascular devices. The emergence of bioresorbable technologies and a shift toward outpatient vascular interventions are reshaping care delivery models. Innovations in materials and the advancement of next-generation stents and catheters are further improving therapeutic efficacy. Additionally, favorable reimbursement frameworks and increased healthcare investment are creating a supportive environment for broader device utilization. Collectively, these factors are expected to sustain market growth over the forecast period.
Market Drivers
Aging Demographics and Healthcare Spending Growth
A key market driver is the aging U.S. population, which is increasingly prone to vascular disorders such as PAD. By 2034, the population aged 65 and older is projected to exceed 77 million, significantly boosting demand for vascular interventions. This demographic shift, coupled with rising healthcare expenditures and enhanced access to medical services, is fostering greater adoption of peripheral vascular devices. These trends are expanding treatment accessibility, thereby accelerating market growth.
Market Challenges Analysis
High Cost of Advanced Peripheral Vascular Devices
The high cost associated with peripheral vascular devices remains a significant challenge for market expansion. Cutting-edge interventions, including stents, balloons, and catheters, entail extensive R&D and regulatory processes, resulting in elevated production costs. For example, the development of new stent technologies requires comprehensive clinical validation and approval, which contributes to pricing pressures. These expenses are frequently transferred to healthcare providers and patients, limiting affordability—particularly for those with limited or no insurance coverage. Although increased demand may offset some financial burdens, the introduction of premium technologies such as bioresorbable stents and drug-eluting devices intensifies the cost barrier, constraining widespread adoption.
Market Segmentation
By Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Guidewires
Others
By End-User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Geography:
Western United States
Midwestern United States
Southern United States
Northeastern United States
Key Player Analysis
Abbott Laboratories
Boston Scientific Corporation
Medtronic plc
Terumo Corporation
Becton, Dickinson and Company
Cardinal Health
Cook Medical
Koninklijke Philips N.V.
AngioDynamics, Inc.
Biotronik SE & Co. KG
Table of Contents
187 Pages
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. U.S. Peripheral Vascular Devices Market Snapshot
- 2.1.1. U.S. Peripheral Vascular Devices Market, 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : U.S. Peripheral Vascular Devices Market – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. U.S. Peripheral Vascular Devices Market Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups /SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : U.S. Peripheral Vascular Devices Market – BY Based on Type: ANALYSIS
- CHAPTER NO. 7 : U.S. Peripheral Vascular Devices Market – BY Based on End-user: ANALYSIS
- CHAPTER NO. 8 : U.S. Peripheral Vascular Devices Market – BY Based on the Geography: ANALYSIS
- CHAPTER NO. 9 : COMPANY PROFILES
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Product Portfolio
- 9.1.3. Swot Analysis
- 9.1.4. Business Strategy
- 9.1.5. Financial Overview
- 9.2. Boston Scientific Corporation
- 9.3. Medtronic plc
- 9.4. Terumo Corporation
- 9.5. Becton, Dickinson and Company
- 9.6. Cardinal Health
- 9.7. Cook Medical
- 9.8. Koninklijke Philips N.V.
- 9.9. AngioDynamics, Inc.
- 9.10. Biotronik SE & Co. KG
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
